Harald Polzer
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
-
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 6
- Hematopoietic Stem Cell Transplantation 1
-
- Histone Deacetylase Inhibitors Research 3
- Protein Degradation and Inhibitors 2
- PI3K/AKT/mTOR signaling in cancer 1
- Co-authors
- Karsten Spiekermann (8 shared papers)Hanna Janke (3 shared papers)Oliver H. Krämer (2 shared papers)Thomas Büchner (1 shared paper)Friederike Pastore (1 shared paper)Gesine Bug (1 shared paper)Wolfgang Hiddemann (2 shared papers)Stefan K. Bohlander (2 shared papers)
- Journals
- Scientific Reports (2 papers)Blood (2 papers)Molecular Cancer Therapeutics (1 paper)European Journal of Medicinal Chemistry (1 paper)PLoS ONE (1 paper)
- Partner nations
- GermanyNew Zealand
In The Last Decade
Harald Polzer
8 papers receiving 141 citations
Peers
Comparison fields: 5 of 19
- Hematology 111
- Genetics 39
- Molecular Biology 83
- Cancer Research 10
- Oncology 18
Countries citing papers authored by Harald Polzer
This map shows the geographic impact of Harald Polzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Polzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Polzer more than expected).
Fields of papers citing papers by Harald Polzer
This network shows the impact of papers produced by Harald Polzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Polzer. The network helps show where Harald Polzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Harald Polzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 50 | |
| 2 | 2012 | 42 | |
| 3 | 2015 | 14 | |
| 4 | 2020 | 14 | |
| 5 | 2016 | 10 | |
| 6 | 2012 | 9 | |
| 7 | 2012 | 1 | |
| 8 | 2015 | 1 | |
| 9 | 2015 | 0 |
About Harald Polzer
Harald Polzer is a scholar working on Hematology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 141 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers), Histone Deacetylase Inhibitors Research (3 papers), Protein Degradation and Inhibitors (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Hematopoietic Stem Cell Transplantation (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Hematology (111 citations), Genetics (39 citations), Molecular Biology (83 citations), Cancer Research (10 citations) and Oncology (18 citations). Harald Polzer has collaborated with scholars based in Germany and New Zealand. Frequent co-authors include Karsten Spiekermann, Hanna Janke, Oliver H. Krämer, Thomas Büchner, Friederike Pastore, Gesine Bug, Wolfgang Hiddemann, Stefan K. Bohlander, Tobias Herold and Karl‐Peter Hopfner. Their work appears in journals such as Scientific Reports, Blood, Molecular Cancer Therapeutics, European Journal of Medicinal Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.